What does kidney cancer metaphase treatment method have

summary

The emergence of renal cancer, will bring great influence to people's own. It is understood that kidney cancer has gradually become the second killer of bladder cancer. Because the malignant degree of renal cell carcinoma is very high, its development speed is also very fast. So what is the mid-term treatment of renal cell carcinoma? Now let's take a look at the specific introduction.

What does kidney cancer metaphase treatment method have

1、 The sensitivity of chemotherapy and radiotherapy for renal cell carcinoma is very low, the efficiency is only 10%. Moreover, chemotherapy itself is easy to produce drug resistance, and the specificity is also relatively poor. 　　

2、 For metastatic renal cell carcinoma, the five-year survival rate of distant metastasis is generally about 5%, which is very low. At present, there is no particularly good method for treatment except operation. Surgery is best not only to cut off the kidney tumor, but also to cut off the metastatic lesions. For some patients with renal cancer, although the effect is better after surgery, there are still 1 / 3 people who will have metastasis after surgery. Therefore, the treatment of metastatic renal cell carcinoma often requires more thorough and comprehensive. 　　

3、 Immunotherapy for kidney cancer, doctors will also use drugs such as interferon and interleukin. Among them, interleukin is likely to cure renal cancer, but its toxic reaction is too large. Whether interferon can improve the life span of patients is still uncertain.

matters needing attention

In the life of renal cancer, we should first seize the time to receive treatment. Only active treatment, can guarantee not be troubled by the disease, at the same time to choose a comprehensive ability of strong hospital, so as to ensure the effect of treatment, and in life, during the treatment can not forget nursing.